Rhabdomyolysis and lipid-lowering drugs.
Tenenbaum
Alexander
A
Fisman
Enrique Z
EZ
Motro
Michael
M
D002995:Clofibric Acid / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced / Q000453:epidemiology*; D012306:Risk
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D002995:Clofibric Acid